6UIT
HIV-1 wild-type reverse transcriptase-DNA complex with dCTP
6UIT の概要
| エントリーDOI | 10.2210/pdb6uit/pdb |
| 分子名称 | p66 Reverse transcriptase/RNaseH, p51 Reverse transcriptase/RNaseH, DNA primer, ... (8 entities in total) |
| 機能のキーワード | hiv-1 reverse transcriptase nrti polymerase dna complex, viral protein |
| 由来する生物種 | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1) 詳細 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 132858.48 |
| 構造登録者 | |
| 主引用文献 | Hung, M.,Tokarsky, E.J.,Lagpacan, L.,Zhang, L.,Suo, Z.,Lansdon, E.B. Elucidating molecular interactions ofL-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance. Commun Biol, 2:469-469, 2019 Cited by PubMed Abstract: Emtricitabine (FTC) and lamivudine (3TC), containing an oxathiolane ring with unnatural (-)-stereochemistry, are widely used nucleoside reverse transcriptase inhibitors (NRTIs) in anti-HIV therapy. Treatment with FTC or 3TC primarily selects for the HIV-1 RT M184V/I resistance mutations. Here we provide a comprehensive kinetic and structural basis for inhibiting HIV-1 RT by (-)-FTC-TP and (-)-3TC-TP and drug resistance by M184V. (-)-FTC-TP and (-)-3TC-TP have higher binding affinities (1/) for wild-type RT but slower incorporation rates than dCTP. HIV-1 RT ternary crystal structures with (-)-FTC-TP and (-)-3TC-TP corroborate kinetic results demonstrating that their oxathiolane sulfur orients toward the DNA primer 3'-terminus and their triphosphate exists in two different binding conformations. M184V RT displays greater (>200-fold) for the -nucleotides and moderately higher (>9-fold) for the -isomers compared to dCTP. The M184V RT structure illustrates how the mutation repositions the oxathiolane of (-)-FTC-TP and shifts its triphosphate into a non-productive conformation. PubMed: 31872074DOI: 10.1038/s42003-019-0706-x 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.80607409399 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






